Regulatorische Updates
24. Aug. 2026•1 Min. Lesezeit
MHRA Updates Safety Warnings for Finasteride and Dutasteride Over Suicide Risk
The UK regulator advises new measures to reduce suicide risk linked to finasteride and dutasteride.
Regulatorische Updates
24. Aug. 2026•1 Min. Lesezeit
MHRA reminds of serious amiodarone risks and need for patient monitoring
Amiodarone linked to life‑threatening lung, liver and thyroid side effects; MHRA urges healthcare professionals to supervise and review patients.
Regulatorische Updates
24. Aug. 2026•1 Min. Lesezeit
MHRA Issues Updated Warning on Botulinum Toxin Type‑A Products Over Risk of Iatrogenic Botulism
The UK Medicines and Healthcare products Regulatory Agency reports cases of iatrogenic botulism after therapeutic or cosmetic use of botulinum toxin type‑A, urging immediate medical attention if symptoms arise.
Regulatorische Updates
24. Aug. 2026•1 Min. Lesezeit
MHRA adds contraindication for domperidone in pheochromocytoma patients
MHRA updates domperidone product information to contraindicate use in confirmed or suspected pheochromocytoma due to severe hypertension risk.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Doncaster Pharma alerts MHRA over Braille embossing error on Hiprex 1 g tablets
Doncaster Pharma reported a Braille embossing error on the outer packaging of certain parallel‑imported Hiprex 1 g tablets to the MHRA.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
MHRA Publishes Field Safety Notices for 13‑17 April 2026
The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices issued between 13 and 17 April 2026.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Omega Pharma Recalls Napralief 250mg Tablets Over Missing PIL Text
Omega Pharma Ltd is recalling specific batches of Napralief 250mg gastro‑resistant tablets because sections of the patient information leaflet and carton labeling are missing.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Amarox Limited recalls Sertraline 100 mg tablets batch over manufacturing error
Amarox Limited is recalling a batch of 100 mg film‑coated sertraline tablets due to a manufacturing site error.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
MHRA Issues April 2026 Safety Advice for Medicines and Devices
The UK MHRA released its April 2026 safety roundup, summarising the latest advice for medicine and medical device users.
1
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
MHRA Publishes Field Safety Notices for 20‑24 April 2026
The UK Medicines and Healthcare products Regulatory Agency (MHRA) released a list of Field Safety Notices covering 20‑24 April 2026.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
MHRA Publishes Field Safety Notices on 1 May 2026
The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices on 1 May 2026.
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
MHRA Publishes Field Safety Notices for 4–8 May 2026
The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering the period 4 to 8 May 2026.